Adalimumab Induced Pulmonary Sarcoid Reaction

Overview

Journal Respir Med Case Rep

Date 2015 Jun 2

PMID 26029514

Citations 10

Authors

S Bhargava

D M Perlman

T L Allen

J H Ritter

M Bhargava

Affiliations

Soon will be listed here.

Abstract

Sarcoidosis is a multisystem granulomatous inflammatory disease of unknown etiology. There is evidence that Tumor Necrosis Factor alpha (TNF-α) antagonists are useful in the treatment of advanced or refractory disease. However, sarcoidosis-like reaction has been reported with TNF-α blockade in other inflammatory conditions. Here we report a case of sarcoid-like reaction in a patient with psoriatic arthritis shortly after initiation of adalimumab therapy. Stopping adalimumab and systemic anti-inflammatory therapy with corticosteroids resulted in resolution of pulmonary symptoms and chest radiographic findings. Though TNF-α plays a critical role in pathogenesis of sarcoidosis, the development of sarcoid reaction with TNF-α blockade is paradoxical and the mechanism of this response remains unknown. TNF-α induced sarcoid-reaction could involve multiple organs. Its development with one agent does not preclude therapy with other TNF-α blockers.

Citing Articles

Sarcoidosis-Like Reaction in a Patient With Psoriatic Arthritis Treated With Adalimumab.

Oliveira J, Arandjelovic M, Pintor I, Resendes M, Pereira F Cureus. 2025; 16(12):e76563.

PMID: 39881908 PMC: 11774629. DOI: 10.7759/cureus.76563.

FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis.

Bullock C, McCann M, Sharma A, Young J, Metcalfe A, Parent E Radiol Case Rep. 2023; 18(11):3932-3935.

PMID: 37663559 PMC: 10472138. DOI: 10.1016/j.radcr.2023.08.005.

Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders.

Caldito N Front Immunol. 2023; 14:1213448.

PMID: 37483590 PMC: 10360935. DOI: 10.3389/fimmu.2023.1213448.

Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis.

Bernardinello N, Petrarulo S, Balestro E, Cocconcelli E, Veltkamp M, Spagnolo P Diagnostics (Basel). 2021; 11(9).

PMID: 34573900 PMC: 8472810. DOI: 10.3390/diagnostics11091558.

Lymphadenopathy and granulomas: benignancy of malignancy and differential diagnosis with endobronchial ultrasound-transbronchial needle biopsy 19G needle fine-needle aspiration biopsy.

Zarogoulidis P, Hatzibougias D, Tsakiridis K, Matthaios D, Hohenforst-Schmidt W, Huang H Lung Cancer Manag. 2021; 10(3):LMT49.

PMID: 34408790 PMC: 8369527. DOI: 10.2217/lmt-2021-0002.

References

van der Stoep D, Braunstahl G, van Zeben J, Wouters J . Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge. J Rheumatol. 2009; 36(12):2847-8. DOI: 10.3899/jrheum.090307. View

Takahashi H, Kaneta K, Honma M, Ishida-Yamamoto A, Ashida T, Kohgo Y . Sarcoidosis during infliximab therapy for Crohn's disease. J Dermatol. 2010; 37(5):471-4. DOI: 10.1111/j.1346-8138.2010.00861.x. View

Judson M, Baughman R, Costabel U, Flavin S, Lo K, Kavuru M . Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008; 31(6):1189-96. DOI: 10.1183/09031936.00051907. View

Cathcart S, Sami N, Elewski B . Sarcoidosis as an adverse effect of tumor necrosis factor inhibitors. J Drugs Dermatol. 2012; 11(5):609-12. View

Baughman R, Drent M, Kavuru M, Judson M, Costabel U, du Bois R . Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006; 174(7):795-802. DOI: 10.1164/rccm.200603-402OC. View

Newman L, Rose C, Bresnitz E, Rossman M, Barnard J, Frederick M . A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004; 170(12):1324-30. DOI: 10.1164/rccm.200402-249OC. View

Iannuzzi M, Rybicki B, Teirstein A . Sarcoidosis. N Engl J Med. 2007; 357(21):2153-65. DOI: 10.1056/NEJMra071714. View

Rossman M, Newman L, Baughman R, Teirstein A, Weinberger S, Miller Jr W . A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2007; 23(3):201-8. View

Mohan N, Edwards E, Cupps T, Slifman N, Lee J, Siegel J . Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol. 2004; 31(10):1955-8. View

10.

Mease P . Update on treatment of psoriatic arthritis. Bull NYU Hosp Jt Dis. 2012; 70(3):167-71. View

11.

Ehlers S . Tumor necrosis factor and its blockade in granulomatous infections: differential modes of action of infliximab and etanercept?. Clin Infect Dis. 2005; 41 Suppl 3:S199-203. DOI: 10.1086/429998. View

12.

Ziegenhagen M, Muller-Quernheim J . The cytokine network in sarcoidosis and its clinical relevance. J Intern Med. 2003; 253(1):18-30. DOI: 10.1046/j.1365-2796.2003.01074.x. View

13.

Louie G, Chitkara P, Ward M . Relapse of sarcoidosis upon treatment with etanercept. Ann Rheum Dis. 2008; 67(6):896-8. PMC: 11057365. DOI: 10.1136/ard.2007.078840. View

14.

Wollina U, Hansel G, Koch A, Schonlebe J, Kostler E, Haroske G . Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2007; 9(1):1-14. DOI: 10.2165/00128071-200809010-00001. View

15.

Marcella S, Welsh B, Foley P . Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis. Australas J Dermatol. 2011; 52(3):e8-11. DOI: 10.1111/j.1440-0960.2010.00660.x. View

16.

Hubscher O, Re R, Iotti R . Pulmonary rheumatoid nodules in an etanercept-treated patient. Arthritis Rheum. 2003; 48(7):2077-8. DOI: 10.1002/art.11154. View

17.

Williams V, Cohen P . TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol. 2011; 50(5):619-25. DOI: 10.1111/j.1365-4632.2011.04871.x. View

18.

Dhaille F, Viseux V, Caudron A, Dadban A, Tribout C, Boumier P . Cutaneous sarcoidosis occurring during anti-TNF-alpha treatment: report of two cases. Dermatology. 2010; 220(3):234-7. DOI: 10.1159/000275676. View

19.

Clementine R, Lyman J, Zakem J, Mallepalli J, Lindsey S, Quinet R . Tumor necrosis factor-alpha antagonist-induced sarcoidosis. J Clin Rheumatol. 2010; 16(6):274-9. DOI: 10.1097/RHU.0b013e3181efa190. View

20.

Utz J, Limper A, Kalra S, Specks U, Scott J, Vuk-Pavlovic Z . Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003; 124(1):177-85. DOI: 10.1378/chest.124.1.177. View